You need Adobe Flash and Javascript to view this file Ny_forside
Prediction of Mild Cognitive Impairment that Evolves into Alzheimer’s Disease Dementia within Two Years using a Gene Expression Signature in Blood: A Pilot Study
DiaGenic's pilot study demonstrates for the first time that Mild cognitive impairment that evolves into Alzheimer’s Disease dementia within 2 years may be predicted by analyzing gene expression in blood.
Read more about Prediction of Mild Cognitive Impairment that Evolves into Alzheimer’s Disease Dementia within Two Years using a Gene Expression Signature in Blood: A Pilot Study
Notice to the Oslo Stock Exchange Thu, 23 May 2013 11:31:21 +0200
Annual General Meeting held
Read moreCalendar
23.05.2013 - at 10:00 hours CET - Oslo, Norway
Annual General Meeting, 23rd of May at 10.00 - Oslo, Norway
Annual General Meeting in DiaGenic ASA to be held on 23 May 2013 at 10:00 hours CET at DiaGenic’s premises: Grenseveien 92, 0663 Oslo, Norway.
Read more about Annual General Meeting, 23rd of May at 10.00 - Oslo, Norway